Home Page


ERADA Technology Alliance Ltd (ERADA)

ERADA was founded by Dr Benji Pretorius and Dr Richard Schmidt, located in Musina, South Africa.

This was done after a unique collaborative effort between the South Africans, Johns Hopkins University and Dinglasan Malaria Laboratory in Florida, US. From the drastic need for new innovation in fighting Malaria,  the SMAART diagnostic technology was born and inspired Dr Pretorius to marry the science with solid, ethical business. The fight to END Malaria will be stronger than before and will drive the vision to eliminate Malaria and other infectious diseases.


 “Your work is going to fill a large part of your life, and the only way to be truly satisfied is to do what you believe is great work. And the only way to do great work is to love what you do.”
— Steve Jobs, co-founder, Chairman and CEO of Apple Inc.

At Erada Technology Alliance, we love what we do. What could be better than to have the core determination to deliver a product to the world that could save 450 000 lives per year, prevent the long-term debilitating effects on millions of others and save world medical organizations tens of billions of dollars. We are truly satisfied and we believe we are doing great work.

We named our company ‘Erada’ because of one of the definitions of the word – “The will to conquer against all odds”. As an effective team we are determined to focus our ability to tackle the most difficult medical diagnostic problems with courage and innovation. We will succeed in our goal, of that we have no doubt, we have the right people, and organizations do not create success – people do.

We will nurture our people, we will develop close relationships with our supplier partners and we will display the courage and innovation needed to provide a solution the world needs.

Our Vision

Global, large scale screening to eradicate and therefore finally eliminate detectable and treatable infectious diseases, including Malaria. 

Our Mission

ERADA Rapid Diagnostic Technology to be developed and brought to the global market:
  • For accurate detection of early asymptomatic infection and disease carriers.
  • For accurate diagnosis of acute symptomatic infection.
  • To be the Diagnostic Technology of choice to support Vaccination programs and further Vaccination development.
  • To be the Diagnostic Technology of choice to support Treatment – and Monitoring of infection.


ERADA collaborates with the following partners:

Dinglasan Malaria Laboratory

Dinglasan Malaria Laboratory established in 2009 as part of the Johns Hopkins Malaria Research Institute prior to its transfer to the University of Florida’s Emerging Pathogens Institute in 2016. 

The lab leverages multi-omics approaches to discover, validate and eventually develop enabling technologies focused on malaria elimination and eradication.

Oasis Diagnostics® Corporation 

Oasis Diagnostics® Corporation founded in 2002 to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics [DNA, RNA and proteins] in the Life Sciences and Diagnostics areas.

The Company is dedicated to meeting the need for more effective screening tools, which may be applied to the early detection of diseases and medical disorders, utilising non-invasive test specimens, particularly oral fluids (saliva).

Fusion Antibodies

Fusion Antibodies  a Contract Research Organisation (CRO) established in 2001 and located in Northern Ireland, UK. Its mission is to enable biopharmaceutical and diagnostic companies to develop innovative products in a timely and cost-effective manner for the benefit of the global healthcare industry.


Award-winning Montpellier is proud to be associated with ERADA Technology Alliance and it’s world-first SALVA Malaria Rapid Test. Montpellier comprise three world-beating marketing services consultancies,  providing ERADA with top drawer public relations capabilities delivered by trained journalists, mouth-watering branding design and creative services and state-of-the-art digital and web services.

Research Collaboration

Erada Technology Alliance Ltd is interested in partnering with academic laboratories that will support the mission of the company and the development and testing of our existing technologies.  We welcome the opportunity to work with such labs through collaborative research agreements, with the stipulation that funds from Erada Technology Alliance for a specific scope of work can only support indirect costs up to 30% of the total direct budget. Higher indirect cost rates cannot be accepted.

If this type of collaboration is of interest to your organisation, please contact us through the contact page and one of our senior Management team will be pleased to open discussions with you.

IMAGE CREDIT: MMV (Medicines for Malaria Venture)


Saliva-based Malaria Asymptomatic & Asexual Rapid Test

This technology is a non-invasive diagnostic for the detection of sexual stage Plasmodium falciparum gametocytes, a critical component for successful human-mosquito-human transmission of the malaria parasite. Gametocytes, comprising <2% of the parasite biomass, circulate in tandem with low-level asexual blood stage parasites in asymptomatic or subclinical infections. These asexual blood stages cyclically rise in concentration leading to clinical disease (malaria) resulting in higher numbers of gametocytes as well, which drive transmission to mosquitoes. Saliva is used to test for the presence of the gametocytes in the microvasculature using high-affinity antibodies to a parasite protein that is abundant in saliva in asymptomatic individuals.  Importantly, the diagnostic targets a novel Biomarker of malaria parasites to combat the threat posed by naturally occurring and spreading mutations in the parasite that are rendering the top of the line blood-based rapid tests ineffective. Since the technology is designed to detect very low parasite numbers, it has immediate utility in confirming malaria infection in symptomatic individuals that present to the clinic.


Managing Director

Dr Benjamin (Benji) Pretorius

As the Founder and Principle of Erada Technology Alliance Ltd, Benji brings a great deal to the table as Managing Director. Educated in South Africa, he initially studied as a Biokineticist and became a lecturer in Physiology and Anatomy at the University of North-West, where he was later recognized for his achievements by the pharmaceutical giant Eli Lilly as part of their ‘Future Leader’ award program.

His skills as a General Medical practitioner  were honed at a number of hospitals throughout South Africa and he undertook appointments as an Emergency Unit Doctor which he still holds today. Throughout his time as a medical practitioner Benji has always been driven by the challenges and rewards of research, resulting in him becoming Director Operations and Clinical Research Unit Head at Parexel, Port Elizabeth.

Benji is still actively involved at the sharp end of medicine, as a Senior Partner in a very busy Family Medicine and General Medical practice in Musina, where he counts amongst his major corporate clients, De Beers, Coal of Africa, SF Health and Swanepoel & Partners. It was here that Benji and his partner founded Musina Ventures Ltd, a company focused on Strategic Investment in medical technology and general business consultancy services.

Like many medical practioners in Africa, Benji has faced the challenges of dealing with Malaria throughout his career. His expertise was in demand by the prestigious John Hopkins University in the USA where he has provided Malaria Management and Diagnostics consultancy. One event in Benji’s life that was an inspiration in his drive to find a major contribution in the reduction of Malaria was when he was unfortunate enough to contract the disease himself. He knows first-hand the debilitating effects of Malaria and is acutely aware that the ability to rapidly and accurately diagnose the disease is a significant step in treating patients before long-term damage is sustained. The added benefit of being able to accurately identify ‘carriers’ of the disease will also provide a significant contribution towards the ultimate eradication of Malaria.

Benji’s vision, drive and experience will lead Erada Technology in our mission to identify and eradicate Malaria. In what little spare time Benji has, he is a devoted family man to his Wife and two Daughters.



George Duncan

As Director of New Business Development, George is responsible for identifying new business partners, suppliers and markets to meet the vison and goals of Erada Technology Alliance. He ensures, in coordination with our Marketing Group, that our path to providing operational products to our clients is as short and effective as possible.


George began his career as a military pilot with the UK’s Royal Air Force. He then set up a number of very successful businesses associated with ‘Aviation training’ and was one of the first people to implement the now-mandatory program designed to reduce human error in aviation, worldwide. The program is recognized as having significantly reduced the number of aircraft accidents caused by human error in both military and commercial aviation environments across the globe. George then incorporated this successful strategy in both the petrochemical and medical industry.


George has provided cutting edge consultancy to medical and surgical teams in general practices and hospitals, focused on reducing human errors which can lead to situations causing unnecessary harm to patients. Human error in life and business critical situations is a problem across industry and the medical sector is no exception. His expertise in fatigue and the limits of Human performance have been widely acknowledged resulting in him being invited as a key note speaker at symposiums around the world.


Having been responsible for more than five successful start-up businesses and the timely recovery and development of other multi-national businesses, his experience and innovation will help drive our business development plan forward and his expertise in leadership and Human Factors will be of benefit to all of our team and our business as a whole.


George is married with four children and his passions include reading and studying quantum mechanics.


Director Clinical Development

Dr Richard Schmidt

Dr Richard Schmidt is an experienced general family practice doctor, emergency medicine physician, occupational medical practitioner and business entrepreneur.


His career started with 7 Medical Battalion Group, the specialist Airborne Medical Battalion of the South African Military Health Service. In this group he rendered emergency medical support to the South African Special – and Airborne Forces.


His MBChB (medicine and surgery) degree from the University of Pretoria, was completed during his military career with general practitioner work following in New Zealand and South Africa.


He qualified as an Occupational Medical Practitioner, also through the University of Pretoria, and currently provides day to day support to De Beers South Africa and various other industries as part of the occupational health practice in Musina, South Africa.


He played an essential role in building the Swanepoel & Partners medical practice in Musina, since 2013 and still manages this busy practice everyday with annual growth and successes. Malaria management and interaction with key opinion leaders in the the infectious disease and Malaria fields, supported the initiative to found Musina Ventures (Pty) Ltd and Erada Technology Alliance Ltd (Erada).


Dr Schmidt with his strong clinical, analytical and practical business skills, provide the foundation to act as the clinical development director for Erada and will function at top level together with the likes of Dinglasan Malaria laboratory in Florida, US and other associated clinical development partners.


His passion for people, life and finding solutions to make a difference, make him a loving and caring family man, with high ethical medical and business values.










What has Covid-19 revealed about the way we handle global pandemics?

Covid-19 has taught us crucial lessons in how we as a global community react to and manage pandemics. It is essential that we learn from these lessons and protect vulnerable communities from the next disease outbreak, whenever that might be. Throughout Covid-19, preventative measures for other diseases such as malaria have continued. As a survivor…

Malaria Week 2020: “Continued collaboration and innovation are key to preventing malaria”

Our founder, Dr Benji Pretorius, states that essential ongoing collaboration is essential for the Asia Pacific region to eradicate malaria by 2030. His message came at the same time as Malaria Week was taking place in Hanoi, Vietnam, providing a platform for information exchange and dialogue between regional and global stakeholders supporting the region’s ambition…

The challenge of tackling malaria in the Solomon Islands

Members of the Asia Pacific Leaders Malaria Alliance (APLMA) and Asia Pacific Malaria Elimination Network (APMEN), met on the 7th to 11th of September for Malaria Week. Hosted virtually in Vietnam, it was a week to discuss progress, innovations and challenges towards member countries’ commitment to ending malaria by 2030, culminating in endorsing a five-year…

We must continue forwards in the fight against malaria

Dr Benji Pretorius warns that more than a decade of progress made in the fight to end malaria will be reversed if prevention methods are halted during the current COVID-19 outbreak. His warnings come in the wake of reports from the World Health Organization (WHO) of the suspension of insecticide-treated nets (ITNs) and indoor residual…

Will Climate Change Cause Millions More to Die from Malaria?

The spectre of climate change threatening our futures is a conversation that has been dropped in recent months in the wake of Covid-19. But it has not gone away and will continue to haunt us in the years to come. What is at stake is not climate change’s effects on malaria directly, but on human…

Why we must keep going forwards in malaria prevention

2020 was heralded as the year the global community stepped up its fight to eradicate malaria once and for all. Slowing death rates and mortality1, coupled with advancements in detection and research, painted an encouraging picture. Now Covid-19 threatens to derail the significant progress we have made. Malaria still takes the lives of 400 000…

Named one of the Top 100 Health & MedTech startups

We are proud to have been named as one of the top 100 health and medtech startups for 2020 by HexGn – an international group of investors, based in New Delhi. HexGn’s network of more than 20 000 investors delivers global reports on the latest investment opportunities, and offers an accelerator programme for start-up businesses…

A View from the Field – World Malaria Day version

The latest version of our quarterly newsletter, A View from the Field, is now available. This issue features a World Malaria Day message from our founder, Dr Benji Pretorius on the need for malaria prevention projects to continue in the midst of the Covid19 pandemic. Read A View from the Field here.

A World Malaria Day message from our founder

“We are on a mission to save lives.” Dr Benji Pretorius has a special message from the South Africa-Zimbabwe border for World Malaria Day 2020. As the world tries to cope with the Covid19 pandemic, Dr Pretorius – who himself survived malaria – stresses the importance of maintaining current progress in malaria prevention even in…

Malaria prevention cannot be allowed to stall during Covid19, warns Erada founder

Dr Benji Pretorius urges continued focus on the detection and diagnosis of the disease during the Covid19 pandemic. Dr Pretorius, founder of Erada Technology Alliance, warns that recent progress made in the fight to end malaria will be undone if prevention methods are halted due to the Covid19 outbreak. His warning comes as the World…


Malaria Facts and Figures


ERADA Technology Alliance Ltd.

ICT Avenue, The Core

Cybercity, Ebene

T: +27 (061) 119-1591

E: info@www.eradatechnology.com